Potentiality of Diethylamine as Agent of Deproteination and Deacetylation in the Extraction of Chitosan from Scylla serrata Shell

The potentiality of diethylamine as deproteination and deacetylation agent in the extraction of chitosan from Scylla serrata (giant mud crab) shell was investigated. The aim was to find an alternative agent to inorganic alkalis as possible replacement for use in the production of high quality chitosan with the right stability. Pretreatment of the shell was carried out and followed by demineralization using hydrochloric acid. Diethylamine was used for deproteination and deacetylation by modifying some published protocols. Moisture, ash, fat and protein contents of the extracts were determined using their respective standard methods. Fourier Transform Infrared (FTIR) technique was used for spectroscopic analysis. Scylla serrata shell was composed of 14.25% protein, 32.84% mineral (CaCO3), 31.52% chitin and 21.39% chitosan. Moisture, ash, fat and protein contents of chitin extracted from Scylla serrata shell were 2.35%, 3.03%, 1.79% and 3.85% respectively while those of chitosan were 1.65%, 3.84%, 0.53% and 2.80% respectively. Degree of deacetylation (DDA) and carbon to nitrogen ratio were 69.24% and 5.67 respectively. FTIR spectra of the extracted chitin and chitosan from Scylla serrata showed the presence of some active compounds of carbonyl, amide, amine and hydroxyl groups. However, CH3 waging along chain (952 cm-1), CO stretching at 1026 cm-1 and 1073 cm-1, and amide II band (1563 cm-1) were not found in the extracted chitin while HPO42- and amide III were also not found in the extracted chitosan. These moieties were present in the standard chitin and chitosan respectively. This study has shown that diethylamine (organic base) has great potential as agent of deproteination and deacetylation in the extraction of chitosan from Scylla serrata. Consequently, academic activity in the area of investigation of the stability of the extracted chitosan from Scylla serrata using diethylamine as deproteination and deacetylation agent is strongly recommended. Keywords: Diethylamine, deproteination, deacetylation, chitin and chitosan, Scylla serrata shell. DOI: 10.7176/CMR/12-7-07 Publication date:October 31st  2020

The Pharmacokinetics and Interactions of Ivermectin in Humans—A Mini-review

Ivermectin is an antiparasitic drug with a broad spectrum of activity, high efficacy as well as a wide margin of safety. Since 1987, this compound has a widespread use in veterinary medicine and it use has been extended in humans. Here we present a brief review of the information availabile regarding the pharmacokinetics and interactions of ivermectin in humans. Awareness of these characteristics could improve the clinical efficacy of Ivermectin. All Authors declare that they do not have any Conflict of interest and that the work is original. All Authors agree that the contents of the manuscript are confidential and will not be copyrighted, submitted, or published elsewhere (including the Internet), in any language, while acceptance by the Journal is under consideration

Global patient outcomes after elective surgery: prospective cohort study in 27 low-, middle- and high-income countries.

BACKGROUND: As global initiatives increase patient access to surgical treatments, there remains a need to understand the adverse effects of surgery and define appropriate levels of perioperative care. METHODS: We designed a prospective international 7-day cohort study of outcomes following elective adult inpatient surgery in 27 countries. The primary outcome was in-hospital complications. Secondary outcomes were death following a complication (failure to rescue) and death in hospital. Process measures were admission to critical care immediately after surgery or to treat a complication and duration of hospital stay. A single definition of critical care was used for all countries. RESULTS: A total of 474 hospitals in 19 high-, 7 middle- and 1 low-income country were included in the primary analysis. Data included 44 814 patients with a median hospital stay of 4 (range 2-7) days. A total of 7508 patients (16.8%) developed one or more postoperative complication and 207 died (0.5%). The overall mortality among patients who developed complications was 2.8%. Mortality following complications ranged from 2.4% for pulmonary embolism to 43.9% for cardiac arrest. A total of 4360 (9.7%) patients were admitted to a critical care unit as routine immediately after surgery, of whom 2198 (50.4%) developed a complication, with 105 (2.4%) deaths. A total of 1233 patients (16.4%) were admitted to a critical care unit to treat complications, with 119 (9.7%) deaths. Despite lower baseline risk, outcomes were similar in low- and middle-income compared with high-income countries. CONCLUSIONS: Poor patient outcomes are common after inpatient surgery. Global initiatives to increase access to surgical treatments should also address the need for safe perioperative care. STUDY REGISTRATION: ISRCTN5181700

Photonically Integrated Multicast Switch on InP as a Transponder Aggregator for ROADM Nodes

We report a multicast switch PIC serving as a transponder aggregator. Successful data transmission through InP multicast switch and reception in a fully packaged coherent receiver demonstrates the drop traffic flow of a ROADM node